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Abstract
Background: Adverse Drug Reactions (ADRs) have been regarded as a major public health problem since they
represent a sizable percentage of admissions. Unfortunately, there is a wide variation of ADR related admissions
among different studies. The aim of this study was to evaluate the frequency of ADR related admissions and its
dependency on reporting and method of detection, urgency of admissions and included medical departments
reflecting department/hospital type within one study.
Methods: The study team of internal medicine specialists retrospectively reviewed 520 randomly selected
medical records (3%) of patients treated in the medical departments of the primary city and tertiary referral
governmental hospital for certain ADRs causing admissions regarding WHO causality criteria. All medical records
were checked for whether the treating physicians recognised and documented ADRs causing admissions. The
hospital information system was checked to ensure ADR related diagnoses were properly coded and the database
of a national spontaneous reporting system was searched for patients with ADRs included in this study.
Results: The established frequency of admissions due to certain ADRs recognised by the study team and
documented in medical records by the treating physicians was the same and represented 5.8% of all patients (30/
520). The frequency of ADR causing admissions detected by employing a computer-assisted approach using an
ICD-10 coding system was 0.2% (1/520), and no patient admitted due to ADRs was reported to the national
reporting system (0/520). The recognized frequency of ADR related admissions also depends on the department's
specialty (p = 0.001) and acceptance of urgently admitted patients (p = 0.001). Patients admitted due to ADRs
were significantly older compared to patients without ADRs (p = 0.025). Gastrointestinal bleeding due to NSAID,
acetylsalicylic acid and warfarin was the most common ADR that resulted in admission and represented 40% of
all certain ADRs (12/30) according to WHO causality criteria.
Conclusion: ADRs cause 5.8% of admissions in medical departments in the primary city and tertiary referral
hospital. The physicians recognise certain ADR related admissions according to WHO causality criteria and note
them in medical records, but they rarely code and report ADRs. The established frequency of ADR related
admissions depends on the detection method, department specialty and frequency of urgently admitted patients.
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Background
Adverse drug reactions (ADRs) have been regarded as a
major public health problem since they represent a siza-
ble percentage of admissions and an economic burden
[1,2]. Unfortunately, there is a wide variation of ADR
related admissions among different European studies. In
a UK study of ADR related admissions in all hospitals
using the computer-assisted International Classification
of Diseases (ICD) coding system ADR related admissions
represented 0.5% of total hospital admissions [3], while
in a prospective observation study in only two hospitals
with medical and surgical departments ADR related
admissions corresponded to 5.2% of total hospital admis-
sions [4]. In a similar prospective observation, European
studies performed in medical departments admissions
due to certain ADRs according to WHO (World Health
Organisation) criteria encounter 3.2% in France [5] and
6.2% in Germany [6] of all admitted patients, while in a
prospective computerised "event monitoring" study in
internal medicine departments in Swiss general and teach-
ing hospitals admissions due to ADRs encounter 3.3% [7].
Studies in some even more specialised departments give
the highest percentages of patients with ADRs on admis-
sion, for example, up to 27.4% of patients had at least one
possible, likely or very likely ADR on admission in medi-
cal intensive care units in France [8]. After comparing dif-
ferent studies we can assume that a wide variation in the
frequency of ADR related admissions could be the result
of different detection methods and specialties of the
included departments and hospitals [9].
The aim of this study was to evaluate the frequency of
ADR related admissions and its dependency on the
method of reporting and detection, urgency of admissions
and included medical departments within one study.
Methods
Patients
The study was conducted in medical departments for
adult patients of the governmental University Medical
Centre Ljubljana (UMCL), the primary city hospital for
the Slovenian capital city of Ljubljana serving a popula-
tion of 400,000 inhabitants and tertiary referral hospital
centre serving a population of 2,000,000. It includes nine
specialised medical departments with 82 regular beds
dedicated to gastroenterology, 74 beds cardiology, 50
beds angiology, 42 beds endocrinology, 32 beds nephrol-
ogy, 26 beds haematology, 14 beds intensive care, 13 beds
pulmonology, and 6 beds to toxicology. Patients with
solid tumours are treated mainly at the Institute of Oncol-
ogy and were not included in the study. The patients are
admitted to medical departments through a medical
emergency department that covers all medical depart-
ments, through outpatient departments of individual spe-
cialised medical departments and those transferred from
other primary hospitals and non-medical departments of
UMCL, or whose admittance was planned for special diag-
nostic procedures or therapy.
Date collection
In the study a team of three internal medicine specialists,
of whom one was a postgraduate in clinical pharmacol-
ogy, retrospectively reviewed 520 complete medical
records with all patient medical documents chosen at ran-
dom by a computer for ADRs causing admissions. The
number of included patients was computed according to
the main aim of the study, which was the evaluation of
ADR related admissions depending on the method of
reporting and detection (3 possible answers), urgency of
admissions (4 possible answers) and medical depart-
ments (9 possible answers). 16 possible answers regarding
the method of reporting and detection, path of admission
and medical department were multiplied by 30 cases per
each answer, giving us 480 patients. Finally, 480 patients
were rounded up to 520, which represents 3% of 17,500
patients hospitalised in medical departments in UMCL in
2006.
The definition of ADRs used in the study was that of the
WHO: "Any noxious and unintended response to a drug
that occurs at doses normally used in humans for the
prophylaxis, diagnosis or therapy of disease" [10]. The
assessment of ADR causality was performed also using the
WHO system [11]. The study team had to reach a consen-
sus decision on the certainty of ADR related admission
and excluded doubtful cases. ADR causing admissions
were considered as certain if ADR had a plausible time
relationship to drug intake, plausible response to with-
drawal, definitive pharmacological or phenomenological
explanation and could not be explained by disease or
other drugs [11]. Patients with ADR on admission who
were not directly responsible as well as those who received
a deliberate or unintentional overdose or relapsed
because of non-compliance were not considered to have
ADR related admission. Afterwards all certain cases of
ADR related admissions regarding WHO causality criteria
were classified according to ADR type. The type of ADR
estimated its preventability and suggested preventive
measures for each ADR such as closer patient clinical and
laboratory monitoring, applying protective measures and
other selection of drugs. These were checked for their fea-
sibility in every patient individually by the study team
revising patient medical documentation.
For all patients age, sex, number of prescribed drugs on
admission, discharge diagnosis with their ICD-10 codes
performed by treating physicians, alcohol abuse, renal
failure, liver failure, urgency and path of admittance and
subspecialty of medical department were recorded. RenalBMC Clinical Pharmacology 2009, 9:8 http://www.biomedcentral.com/1472-6904/9/8
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failure was considered in patients with serum creatinine
levels 50% above the upper normal level (150 micromol/
L) and liver failure in patients with liver enzymes (alanine
aminotransferase, aspart aminotransferase and gamma
glutamyltransferase) at twice the upper normal level.
ADR causing admissions, documented and described in
the medical records by the treating physicians who were
unaware of the study and not specially trained and
encouraged to record, code or report ADRs, were carefully
recorded and additionally reassessed by the study team,
who met to reach a consensus decision on the certainty of
ADR related admission according to WHO causality crite-
ria documented by the treating physicians and excluded
doubtful cases.
Subsequently the hospital information system based on
ICD-10 coding was checked for whether ADR related diag-
noses causing admission of included patients were prop-
erly coded. ICD-10 codes including the words "drug
induced" or "due to" a medicine or which are recognised
to be invariably caused by a drug along with external
cause codes indicating that a drug was implicated were
considered as an ADR related diagnosis. The results of
ADR coding are expressed as the percentage of ADR
related admissions documented by the treating physician
that were not properly coded and the percentage of ADR
related admissions in patients included in this study that
would be established only by searching a hospital infor-
mation system based on ICD-10 coding.
Finally, the Slovenian national spontaneous ADR report-
ing system database was searched for patients with ADR
reported by UMCL in 2006. The Slovenian National Phar-
macovigilance Centre was established in 1984 and has
been a member of Eudravigilance since 2004. The treating
physicians should report all ADRs to the national report-
ing system using the ADR reporting form, but reporting is
spontaneous and no repercussion is followed for not
reporting. In 2006 the National Pharmacovigilance Cen-
tre received 100 ADR reports per one million inhabitants,
mainly from hospital physicians. 20 ADR reports were
sent to the National Pharmacovigilance Centre from
UMCL in 2006. The patients in the national database of
reported ADRs and patients included in this study were
matched according to date, reporting hospital, patient's
initials, age, drugs and reported ADRs. If all matched well,
we assumed this to be the same case. The results of report-
ing ADR related admissions to the national reporting sys-
tem are expressed as a percentage of ADRs described by
the treating physician in medical records that were not
reported to the national spontaneous reporting system
and a percentage of ADR related admissions in patients
included in this study that would be established only by
searching the national spontaneous reporting system
database.
A Slovenian National Medical Ethics Committee
approved this study.
Statistical analysis
The data is presented as the mean and range unless other-
wise indicated. Pearson's correlation was used to correlate
age, number of drugs and number of diagnoses. The anal-
ysis of variance and Bonferroni correction method were
used to analyse the differences in admissions due to ADRs
between established urgency and paths of admission and
subspecialty of included departments. Statistics of patient
characteristics between patients admitted due to ADR and
patients without ADR on admission were compiled by
multivariate logistic regression analysis. A p value of less
than 0.05 was considered to be significant.
Analyses were carried out with the Statistical Package for
Social Science 11.5 for Windows (SPSS).
Results
Study population characteristic
Over one year, from 1 January to 31 December 2006,
17,230 patients were admitted to the medical depart-
ments of UMCL. The study included 520 patients, which
represented 3% of all admitted patients. The overall study
of population characteristics is given in Table 1. Age cor-
related with number of drugs (p = 0.001) and number of
diagnoses (p = 0.001).
Admissions due to ADRs detected in patient medical 
records by a study team
The prevalence of admissions due to certain ADRs accord-
ing to WHO causality criteria detected in medical records
by the study team of internal medicine specialists was
5.8% (30 of 520 admitted patients).
Table 1: Characteristics of the study population (N = 520)
Male * 296 (57%)
Age ** 65.6 (19–94)
Number of drugs on admission ** 4.4 (0–16)
Number of discharge diagnoses ** 5.0 (1–14)
Renal failure * 50 (9.6%)
Liver failure * 52 (10.0%)
Alcohol abuse * 36 (6.9%)
* Number of patients and percentage; **mean and rangeBMC Clinical Pharmacology 2009, 9:8 http://www.biomedcentral.com/1472-6904/9/8
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The difference in admissions due to ADRs between the
established urgency and paths of admission was signifi-
cant (p = 0.001) in global, but the post hoc test results
showed that only ADR related urgent admissions through
the medical emergency department were significantly dif-
ferent from planned admittance (p = 0.001), with a much
higher percentage of admissions (Table 2).
The difference in admissions due to ADRs between the
established departments was significant (p = 0.001) in glo-
bal as well, but the post hoc test results showed that only
ADR related admissions to the department of gastroenter-
ology were significantly different from the departments of
cardiology (p = 0.001) and angiology (p = 0.001), with a
much higher percentage of admissions (Table 3).
The characteristics of patients according to ADR on admis-
sion are presented in Table 4. Patients admitted due to
ADRs were significantly older compared to patients with-
out ADRs (p = 0.025) (Table 4).
Types of ADRs and drug classes that resulted in admission
are presented in Table 5. All ADRs are already known and
labelled. Gastrointestinal bleeding due to NSAID, acetyl-
salicylic acid and warfarin was the most common ADR
that resulted in admission and represented 40% of all
ADRs (12/30). Cardiovascular medications were involved
in 20% of ADRs (6/30), antineoplastic and immunosup-
pressive agents in 13% (4/30), corticosteroids in 13% (4/
30) and antidiabetic drugs in 10% of ADRs (3/30).
Admissions due to ADRs documented in patient medical 
records by treating physicians
The frequency of admissions due to certain ADRs accord-
ing to WHO causality criteria recognised and documented
in medical records by the treating physicians was 5.8% of
all patients (30/520), the same as detected in medical
records by the study team (Table 5). The study team did
not find any incorrectly described or unrecognised certain
ADR according to WHO causality criteria causing admis-
sions by the treating physicians.
Admissions due to ADRs detected in the hospital 
information system by a computer-assisted approach using 
ICD-10 coding
Among 30 patients admitted due to certain ADRs accord-
ing to WHO causality criteria in this study only one
patient (3.3%) had an ADR related disorder properly
coded by ICD-10 (K710 Drug induced liver disease) in the
hospital computer assisted information system. The
under-coding rate of ADRs in this study was 96.7% (29/
30) and prevalence of admissions due to ADR detected by
the computer-assisted approach using the ICD-10 coding
system only 0.2% (1/520).
Admissions due to ADRs reported to the national ADR 
spontaneous reporting system
No patient admitted due to certain ADRs according to
WHO causality criteria in this study was reported to the
national ADR reporting system. The under-reporting rate
in this study was 100% (30/30) and prevalence of admis-
sions due to ADRs reported to the national ADR sponta-
neous reporting system was 0% (0/520).
Discussion
Admissions to medical departments due to certain ADRs
according to WHO causality criteria recognised and docu-
mented in medical records by treating physicians and con-
firmed by the study team in this primary city and tertiary
referral hospital with about 60% of urgently admitted
patients was found in 5.8% of patients, which is similar to
studies performed in other European primary city and ter-
tiary referral hospitals [6].
In this study the established percentage of ADR related
admissions primarily depends on the method used to
detect patients admitted due to ADRs since treating physi-
cians recognised and documented in medical records all
Table 2: Urgency and paths of admission to medical departments
No. of patients admitted regardless of 
ADR (N = 520)
No. of patients admitted due to ADR (%) 
(N = 30)
Urgent admissions through Medical Emergency 
Department
210 23 (11.0%) *
Urgent admissions through Medical 
Outpatients Department
48 3 (6.3%)
Urgent transfer from other primary hospitals 
or departments
49 4 (8.2%)
Non-urgent/planned admissions 213 0 (0%) *
* p = 0.001; urgent admission through Medical Emergency Department v. non-urgent/planned admissionsBMC Clinical Pharmacology 2009, 9:8 http://www.biomedcentral.com/1472-6904/9/8
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certain ADRs according to WHO causality criteria, but
they rarely coded ADR related diagnoses according to
ICD-10 for the hospital information system and never
reported them to the authorities. Accordingly the fre-
quency of ADR related admissions found in the hospital
computer assisted information system based on ICD-10
codes and the database of the spontaneous reporting sys-
tem might grossly underestimate the burden of drug-
induced disorders as a cause of hospital admission as was
also shown in other studies of information systems using
computer assisted coding [3,12,13] and spontaneous
reporting systems [13-16], where a spontaneous underre-
porting system of up to 100% was established as in this
study [17]. The limitation of this study is the low number
of patients admitted due to ADR, which prevents us from
determining spontaneous reporting with a frequency
below 3.3% that could still be useful for signal detection,
particularly for unlabelled ADRs.
In 2006 a spontaneous reporting system in UMCL was
clearly not effective and various initiatives have been
introduced to encourage and facilitate reporting of ADRs
such as grated accessibility to the ADR database through
electronic reporting, education at both undergraduate and
postgraduate level, and rewarding reporters who supply
good quality ADR reports with credit points for continu-
ing education as well as feedback information, whose
effectiveness in increasing reporting have been suggested
and proved in other studies [16,18]. On the other hand,
one of the main reasons for hospital computer assisted
information system underestimation of ADR burden as a
cause of hospital admission is limitations of the coding
system for identifying ADRs [13,19,20]. In particular, the
ICD-10 codes which clearly define a "drug-induced" diag-
nosis are clearly not comprehensive in their scope [13].
Additionally ADR related diagnoses and particularly their
ICD-10 codes may, also be inaccurate, and since physi-
Table 3: Departments of admittance of the study population
Medical departments No. of patients admitted regardless of ADR 
(N = 520)
No. of patients admitted due to ADR (%) (N = 30)
Cardiology 163 4 (2.5%) *
Angiology 74 0 (0%) **
Gastroenterology 72 13 (18.0%) *, **
Endocrinology 68 6 (8.8%)
Haematology *** 47 4 (8.5%)
Intensive Care Medicine 38 2 (5.3%)
Nephrology 32 1 (3.1%)
Pulmonology 21 0 (0%)
Toxicology 5 0 (0%)
* p = 0.001 Department of Gastroenterology v. Department of Cardiology, ** p = 0.001 Department of Gastroenterology v. Department of 
Angiology, *** haematology includes only patients with leukaemia and some lymphomas
Table 4: Characteristics of patients according to ADR on 
admission
No-ADR A-ADR p
Number 490 (94.3%) 30 (5.7%)
Men 281 (57.3%) 15 (50.0%) 0.494
Age * 65.2 (19–94) 71.5 (42–89) 0.025
Number of drugs * 4.3 (0–16) 5.6 (1–12) 0.273
Number of diagnoses * 5.0 (1–14) 5.5 (1–10) 0.674
Renal failure 46 (9.4%) 4 (13.3%) 0.419
Liver failure 50 (10.2%) 2 (6.7%) 0.859
Alcohol abuse 34 (6.9%) 2 (6.7%) 0.195
Death 19 (3.9%) 0 (0%) 0.998
No-ADR patients without ADR; A-ADR patients admitted due to 
ADR; * mean and range.BMC Clinical Pharmacology 2009, 9:8 http://www.biomedcentral.com/1472-6904/9/8
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cians might consider they are used only for administrative
purposes, they may be less concerned with accurate
recording of ICD codes [21].
Future integration of computer systems within hospitals
and the expansion of electronic prescribing and electronic
health records may make ICD codes a more useful practi-
cal tool [19]. Hospitals should also consider interventions
such as developing educational interventions and mecha-
nisms to provide feedback on recording of ADR to hospi-
tal physicians and to improve the identifications and
coding of admissions linked to ADR [3]. However, in
future it would be necessary to develop coding and report-
ing systems independently of treating physicians that are
usually not specially trained to code diagnoses and who
feel great resistance to coding and reporting overwhelm-
ing and well-known type A reactions [14,22]. This could
be achieved by employing specially trained medical
experts that understand the coding system and reporting
to the authorities. Instead of using ICD-10 codes, they
could code ADRs according to The Medical Dictionary for
Regulatory Activities (MedDRA), which is already used in
the National Pharmacovigilance Centre, because a key
requirement is a more detailed breakdown of drugs impli-
cated in ADRs [3] and the inclusion of causality assess-
ment criteria by which the likelihood of ADR being
related to a particular drug can be estimated [3].
Additionally, the established frequencies of ADR related
admissions depend on the subspecialties of medical
departments and acceptance of urgently admitted patients
with the highest prevalence of ADR related admissions to
the Gastroenterology Department through the Medical
Emergency Department. The highest prevalence of ADR
related admissions to the Gastroenterology Department
was the consequence of gastrointestinal bleeding due to
NSAID, which is the fifth most commonly used drug class
in Slovenia according to defined daily dose [23]. How-
ever, with regard to these results, we should bear in mind
that antineoplastic drugs against solid tumours, which are
also a common cause of ADR, were not included in this
study. Therefore studies of ADR related admissions might
give very different results depending on the frequency of
urgently admitted patients through the emergency depart-
ment and subspecialty of included departments reflecting
the type of hospital (primary v. tertiary) and the accept-
ance of different ADR related disorders.
In this study older patients were more likely to develop
ADRs causing hospital admission, as has already been pre-
Table 5: Description of certain ADRs as a cause of admittance
ADR (No. of patients) Class of drugs (No. of patients with ADR/No. of patients with potentially preventable ADR)
Cardiovascular disorders
Bradycardia (4) Beta-adrenergic blocker (2/2) *
Beta-adrenergic blocker and digoxin (2/2) *
Gastrointestinal disorder
Gastrointestinal bleeding (12) Acetylsalicylic acid (4/4) *
Acetylsalicylic acid with NSAID (1/1) *
NSAID (5/4) *
Warfarin (2/2) *
Liver failure (1) Antifungal agent (1/0)
Renal disorders
Renal failure (1) Antineoplastic agent (1/0)
Haematological disorders
Anaemia (2) Antineoplastic agent (1/1) *
Immunosuppressive agent (1/1) *
Pancytopenia (1) Antineoplastic agent (1/1) *
Metabolic disorders
Hypoglycaemia (3) Insulin (2/2) *
Insulin and sulphonyurea (1/1) *
Hyperglycaemia (4) Corticosteroid (4/4) *
Hypokaliemia (1) Diuretic (1/1) *
Hyperkaliemia (1) ACE inhibitor and spironolactone (1/1) *
* Drug dose related ADR (type A)BMC Clinical Pharmacology 2009, 9:8 http://www.biomedcentral.com/1472-6904/9/8
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sented in some similar studies [4,17,24,25], and should
also be considered comparing different studies because
those including younger patients might present a lower
incidence of ADR related admissions [26]. 5.8% of
patients admitted due to ADRs in medical departments
raise the obligatory question of their prevention. 80% or
even more admissions due to ADRs are supposed to be
potentially avoidable because they are dose related reac-
tions, and thus predictable from the known pharmacol-
ogy of the drug by closer patient clinical and laboratory
monitoring, applying protective measures, selecting other
drugs and patient education [1,14,27-29]. Accordingly, in
this study 90% (27/30) of ADRs were potentially prevent-
able. However, the cost benefit and feasibility of such pre-
ventive procedures is questionable since no decrease in
the percentage of admittances due to ADR was found dur-
ing the last decade, despite knowledge of their possible
prevention. The reason could be that potentially prevent-
able dose related ADRs often happen at low drug doses
where further dose reduction is not possible. One of the
frequently mentioned potentially preventable dose
related ADRs is gastrointestinal bleeding due to acetylsal-
icylic acid, but acetylsalicylic acid is mainly used in small
antitrombotic doses and further dose reduction is not rea-
sonable. Nevertheless, physicians and managers must be
aware of the reality of ADRs and focus further preventive
effort on certain drug classes that cause serious or com-
mon potentially preventable drug related admissions such
as NSAID, acetylsalicylic acid, beta-adrenergic blocker,
diuretic, angiotensin-converting enzyme inhibitor,
sulphonyurea, digoxin, corticosteroide and insulin [24]
that also correspond to 82% (28/34) of drug classes caus-
ing ADR related admissions in this study. Although the
preventability is disputable, this study can help us to iden-
tify the most frequent ADRs related to hospitalisations
and target these ADRs to take preventive action [14].
Conclusion
ADRs cause 5.8% of admissions in medical departments
in the primary city and tertiary referral governmental hos-
pital. The physicians recognise and document in medical
records all certain ADRs causing admission according to
WHO causality criteria, but they rarely code ADRs by ICD-
10 codes in a hospital computer assisted information sys-
tem and spontaneously report them to the authorities.
The established frequency of ADR related admissions
depends, besides on the detection method, also on the
specialty of departments and frequency of urgently admit-
ted patients reflecting hospital type.
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